Circling In on Pulmonary Arterial Hypertension: Is It Time to Consider Circular RNA circ_0016070 as a Biomarker and Target for Therapy?

Circling In on Pulmonary Arterial Hypertension: Is It Time to Consider Circular RNA circ_0016070 as a Biomarker and Target for Therapy?

Bibliographic Details
Main Authors:	Laszlo Farkas, Elena A. Goncharova
Format:	Article
Language:	English
Published:	Wiley 2022-07-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	Editorials biomarkers circular RNA pulmonary arterial hypertension
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.122.026798

Similar Items

Circular RNA hsa_circ_0016070 Is Associated with Pulmonary Arterial Hypertension by Promoting PASMC Proliferation
by: Sijing Zhou, et al.
Published: (2019-12-01)

Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update
by: Michele Correale, et al.
Published: (2024-05-01)

Mendelian Randomization in Pulmonary Arterial Hypertension: Unveiling Early Insights With Promise for Future Discoveries
by: Steeve Provencher, et al.
Published: (2024-03-01)

Expression Profiles of circRNAs and Identification of hsa_circ_0007608 and hsa_circ_0064656 as Potential Biomarkers for COPD-PH Patients
by: Yu J, et al.
Published: (2023-11-01)

An Overview of Circulating Pulmonary Arterial Hypertension Biomarkers
by: Joana Santos-Gomes, et al.
Published: (2022-07-01)

Peripheral blood circular RNA hsa_circ_0058493 as a potential novel biomarker for silicosis and idiopathic pulmonary fibrosis
by: Zhounan Cheng, et al.
Published: (2022-05-01)

Biomarkers in Pulmonary Arterial Hypertension
by: Silvana Elena Hojda, et al.
Published: (2022-12-01)

Hsa_circ_0016070/micro‐340‐5p Axis Accelerates Pulmonary Arterial Hypertension Progression by Upregulating TWIST1 Transcription Via TCF4/β‐Catenin Complex
by: Chun‐Xia Huang, et al.
Published: (2022-07-01)

hsa_circNFXL1_009 modulates apoptosis, proliferation, migration, and potassium channel activation in pulmonary hypertension
by: Xin Jin, et al.
Published: (2021-03-01)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Biomarkers in pulmonary arterial hypertension
by: Omar A Minai
Published: (2014-01-01)

Circular RNA—Is the Circle Perfect?
by: Lavinia Caba, et al.
Published: (2021-11-01)

Differential expression and analysis of extrachromosomal circular DNAs as serum biomarkers in pulmonary arterial hypertension
by: Chun Zhang, et al.
Published: (2024-04-01)

Circular RNAs in pulmonary hypertension: Emerging biological concepts and potential mechanism
by: Qian Wang, et al.
Published: (2022-02-01)

Insulin‐like growth factor binding protein‐4: The quest for the breakthrough biomarker in pulmonary arterial hypertension
by: Rodolfo A. Estrada, et al.
Published: (2023-04-01)

Where's the Easy Button? The Many Barriers to Care for Patients With Pulmonary Arterial Hypertension
by: Onix Cantres‐Fonseca, et al.
Published: (2022-11-01)

Circ‐myh8 Promotes Pulmonary Hypertension by Recruiting KAT7 to Govern Hypoxia‐Inducible Factor‐1α Expression
by: Yan Xing, et al.
Published: (2023-04-01)

Prognostic Significance of Proteomics‐Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension
by: Tetsuro Yokokawa, et al.
Published: (2024-06-01)

Serum biomarker for diagnostic evaluation of pulmonary arterial hypertension in systemic sclerosis
by: Lisa M. Rice, et al.
Published: (2018-08-01)

Plasma Circular RNAs hsa_circ_0001953 and hsa_circ_0009024 as Diagnostic Biomarkers for Active Tuberculosis
by: Zikun Huang, et al.
Published: (2018-08-01)

Circulating acetylcholine serves as a potential biomarker role in pulmonary hypertension
by: Yicheng Yang, et al.
Published: (2024-01-01)

CircPMS1 promotes proliferation of pulmonary artery smooth muscle cells, pulmonary microvascular endothelial cells, and pericytes under hypoxia
by: Xiaoyi Hu, et al.
Published: (2024-06-01)

Exosomal circRNAs in the plasma serve as novel biomarkers for IPF diagnosis and progression prediction
by: Wenhua Gan, et al.
Published: (2024-03-01)

Identification of biomarkers related to copper metabolism in patients with pulmonary arterial hypertension
by: Lei Wang, et al.
Published: (2023-01-01)

Identification of TFRC as a biomarker for pulmonary arterial hypertension based on bioinformatics and experimental verification
by: Chuang Yang, et al.
Published: (2024-08-01)

Treatment-related biomarkers in pulmonary hypertension patients on oral therapies
by: Aparna C. Swaminathan, et al.
Published: (2020-11-01)

Circular RNAs hsa-circ0000175 and hsa-circ0044235 in plasma are novel biomarkers for new-onset rheumatoid arthritis
by: Yujie Gao, et al.
Published: (2021-05-01)

Does the Use of Direct Oral Anticoagulants Influence the Incidence of Chronic Thromboembolic Pulmonary Hypertension After Acute Pulmonary Embolism?
by: Takeshi Ogo
Published: (2024-11-01)

Circulating circular RNAs as biomarkers for the diagnosis of essential hypertension with carotid plaque
by: Zebo Zhang, et al.
Published: (2022-10-01)

Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers
by: Dmitrij Arkadievich Oleynikov, et al.
Published: (2022-07-01)

Endothelial cell clonality, heterogeneity and dysfunction in pulmonary arterial hypertension
by: Geoffrey Newcomb, et al.
Published: (2023-12-01)

ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17
by: Junting Zhang, et al.
Published: (2023-12-01)

Right Heart Catheterization—To Do or Not To Do? Introducing a New Diagnostic Algorithm for Pulmonary Hypertension
by: John J. Ryan, et al.
Published: (2022-09-01)

Evolution and optimization of clinical trial endpoints and design in pulmonary arterial hypertension
by: Marco Caccamo, et al.
Published: (2023-07-01)

Sirtuin 3 and Uncouplin Protein 2, the Missing Link Between Genetics, Metabolism, and Pulmonary Arterial Hypertension
by: Annie C. Lajoie, et al.
Published: (2021-12-01)

Recent trends in pulmonary arterial hypertension
by: Rajagopalan Natarajan
Published: (2011-01-01)

Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?
by: A. J. Smits, et al.
Published: (2024-08-01)

Pediatric and Adolescent Pulmonary Hypertension: What Is the Risk of Undergoing Invasive Hemodynamic Testing?
by: Anudeep Jassal, et al.
Published: (2018-03-01)

TIMP-1: A Circulating Biomarker for Pulmonary Hypertension Diagnosis Among Chronic Obstructive Pulmonary Disease Patients
by: Wenjun He, et al.
Published: (2022-02-01)

Carbohydrate Antigen 125 Is a Biomarker of the Severity and Prognosis of Pulmonary Hypertension
by: Yi Zhang, et al.
Published: (2021-07-01)

Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension in Patients With Chronic Obstructive Pulmonary Disease: A Note of Caution
by: Richard Cheng, et al.
Published: (2023-02-01)